| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |